Nevertheless, it is likely that FL118 alone would eliminate some PDAC and CRC tumours, while FL118 in combination with an appropriate chemotherapeutic agent would eliminate some other PDAC and CRC tumours with low levels of DDX5 expression. This evidence concerns the gene DDX5 and colorectal carcinoma.